PPD CEO funds conservative ad campaign
Fred Eshelman, CEO of PPD, has funded a conservative political group that has produced a controversial last minute campaign advert.
Archives for November 4, 2008
AMRI adds non-GMP capacity to Indian plant
An expansion of pilot plant facilities at its operations in Aurangabad, India will help Albany Molecular Research (AMRI) strengthen its position in the Asian drug development sector, according to CEO Thomas D’Ambra.
Caraco’s Detroit plant gets quality warning
Caraco Pharmaceutical Laboratories, in which India’s Sun Pharmaceuticals holds a 76 per cent stake, has joined the list of generics manufacturers issued with an FDA warning on quality control issues.
NeoStem buys its way into China
NeoStem has agreed to acquire China Biopharmaceuticals Holdings in an attempt to capitalise on the manufacturing and marketing opportunities in the nation.
Clinical outsourcing market set to skyrocket, says Kalorama
Cost pressure and the increasing complexity of trials is forcing drugmakers to increasingly turn to outsourcing experts for clinical development, according to a Kalorama Information report.
MonoSol deal for nanocell delivery film
MonoSol Rx has entered into a partnership with Midatech to develop new drug formulations using the companies’ respective expertise in thin film delivery and biocompatible nanocells.